Equivalence studies for complex active ingredients and dosage forms

Journal Title: The AAPS Journal - Year 2005, Vol 7, Issue 4

Abstract

This article examines the United States Pharmacopeia (USP) and its role in assessing the equivalence and inequivalence of biological and biotechnological drug substances and products—a role USP has played since its founding in 1820. A public monograph in theUnited States Pharmacopeia-National Formulary helps practitioners and other interested parties understand how an article’s strenght, quality, and purity should be controlled. Such a monograph is a standard to which all manufactured ingredients and products should conform, and it is a starting point for subsequent-entry manufactures, recognizing that substantial additional one-time characterization studies may be needed to document equivalence. Review of these studies is the province of the regulatory agency, but compendial tests can provide clarity and guidance in the process.

Authors and Affiliations

Lokesh Bhattycharyya, Roger Dabbah, Walter Hauck, Eric Sheinin, Lynn Yeoman, Roger Williams

Keywords

Related Articles

Evaluation of an Innovative Population Pharmacokinetic-Based Design for Behavioral Pharmacodynamic Endpoints

Pre-clinical behavioral pharmacology studies supporting indications like analgesia typically consist of at least three different studies; dose-finding, duration of effect, and tolerance-development studies. Pharmacokinet...

2007 highlights of advances in the pharmaceutical sciences: An American Association of Pharmaceutical Scientists (AAPS) perspective

The American Association of Pharmaceutical Scientists (AAPS) covers the full range of areas of expertise associated with the resolution of concerns pertaining to drugs and drug products. This editorial highlights the ini...

Phosphorothioate Oligonucleotide Quantification by μ-Liquid Chromatography-Mass Spectrometry

Phosporothioate oligonucleotides represent an important class of therapeutic oligonucleotides, in which none-bridging oxygen atoms of the phosphate groups are replaced by sulfur. These oligonucleotides are designed to tr...

Reserpine Inhibit the JB6 P+ Cell Transformation Through Epigenetic Reactivation of Nrf2-Mediated Anti-oxidative Stress Pathway

The online version of this article (doi:10.1208/s12248-016-9901-6) contains supplementary material, which is available to authorized users.

Workshop/conference report—Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays

For quantitative bioanalytical method validation procedure and requirements, there was a relatively good agreement between chromatographic assays and ligand-binding assays. It was realized that the quantitative and quali...

Download PDF file
  • EP ID EP681897
  • DOI  10.1208/aapsj070477
  • Views 76
  • Downloads 0

How To Cite

Lokesh Bhattycharyya, Roger Dabbah, Walter Hauck, Eric Sheinin, Lynn Yeoman, Roger Williams (2005). Equivalence studies for complex active ingredients and dosage forms. The AAPS Journal, 7(4), -. https://europub.co.uk/articles/-A-681897